Today in Healthcare: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Healthcare.

Press releases published on August 10, 2026

9 hours ago

NeOnc Heads into a High-Stakes Week as Highly Anticipated NEO100 Phase 2a Data Readout Nears

Indeterminate GlobeNewswire

9 hours ago

Autoinjectors Market to Grow from USD 127.30 Billion in 2026 to USD 300.46 Billion by 2031, at a CAGR of 18.7% – MarketsandMarkets™

Indeterminate GlobeNewswire

9 hours ago

Dr. Michael O’Brien to Serve IOC Fellowship at Steadman Philippon Research Institute

Indeterminate GlobeNewswire

10 hours ago

ITM Receives Complete Response Letter for ¹⁷⁷Lu-edotreotide (ITM-11)

Indeterminate GlobeNewswire

10 hours ago

Rise in Overnight Demand for Mental Health Support Prompts Kids Help Phone to Launch Urgent Appeal Ahead of Anticipated Jump During Back-to-School Season

Indeterminate GlobeNewswire

11 hours ago

Ernexa Therapeutics Strengthens Board with Veteran Biotech Executive David Polinsky as Company Approaches Clinical Stage

Indeterminate GlobeNewswire

11 hours ago

Xcellon Biologics Acquires GMP Manufacturing Facility from NextCure, Becoming an End-to-End CRDMO for Next-Generation Bioconjugates and Complex Biologics

Indeterminate GlobeNewswire

11 hours ago

NeOnc Reports Second Quarter 2026 Financial Results and Confirms August 12 Topline Phase 2a NEO100 Data Readout

Indeterminate GlobeNewswire

11 hours ago

PerfectServe Ushers in New Era of AI in Voice with Intelligent Answering powered by ConnectiveIQ

Indeterminate GlobeNewswire

11 hours ago

Muscular Dystrophy Association Announces 2026 College Scholarship Recipients, Investing in the Next Generation of Leaders

Indeterminate GlobeNewswire

11 hours ago

Artelo Announces Enrollment of First Patient in a Phase 2 Clinical Trial Evaluating ART27.13 for Treatment of Glaucoma

Indeterminate GlobeNewswire

11 hours ago

CMS Proposed 2027 Medicare Policy Continues Recognition of the FDA’s Section 351 Biologic Pathway

Indeterminate GlobeNewswire

11 hours ago

AIM ImmunoTech Reports Second Quarter 2026 Financial Results and Highlights Significant Operational Execution Advancing Ampligen® Toward Planned Phase 3 Development in Pancreatic Cancer

Indeterminate GlobeNewswire

11 hours ago

Kura Oncology Announces Publication in Blood Highlighting Ziftomenib’s Differentiated Binding Profile and Preclinical Activity

Indeterminate GlobeNewswire

11 hours ago

TOMI Environmental Solutions, Inc. to Hold Conference Call to Discuss Second Quarter 2026 Financial Results on August 14, 2026

Indeterminate GlobeNewswire

11 hours ago

Capricor Therapeutics to Report Second Quarter 2026 Financial Results and Provide Recent Corporate Update on August 13

Indeterminate GlobeNewswire

11 hours ago

Wave Life Sciences Announces Completion of Redomiciliation to Delaware

Indeterminate GlobeNewswire

11 hours ago

NeOnc Technologies to Host Investor Conference Call to Discuss Topline Phase 2a Results for Intranasal NEO100 in Recurrent IDH1-Mutant High-Grade Glioma

Indeterminate GlobeNewswire

11 hours ago

Baird Medical and Alpmed Enter Strategic Partnership to Advance Irreversible Electroporation (IRE) Technology Globally

Indeterminate GlobeNewswire

11 hours ago

Autonomix Medical Congratulates Co-Founder & Chief Medical Officer Dr. Robert Schwartz on Receiving Prestigious 2026 Cardiovascular Tech Forum Lifetime Achievement Award

Indeterminate GlobeNewswire